Anchiano Therapeutics Ltd.

Anchiano Therapeutics Ltd. (ANCN) relating to its proposed merger with Chemomab Ltd. Under the terms of the agreement, and before additional PIPE financing, ANCN shareholders are expected to own only 10% of the combined company.

To receive more information regarding the investigation of Anchiano Therapeutics Ltd. please fill out the form below.